Not available
Quote | DURECT Corporation (NASDAQ:DRRX)
Last: | $0.9159 |
---|---|
Change Percent: | 1.4% |
Open: | $0.8711 |
Close: | $0.9159 |
High: | $0.9159 |
Low: | $0.87 |
Volume: | 33,643 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | DURECT Corporation (NASDAQ:DRRX)
2024-03-27 18:07:09 ET DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript March 27, 2024, 04:30 PM ET Company Participants Tim Papp - CFO Jim Brown - CEO Norman Sussman - CMO Keith Lui - SVP, Business Development, Commercial, Medical Affairs Con...
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire - Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Earnings Call Today, M...
Message Board Posts | DURECT Corporation (NASDAQ:DRRX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $DRRX News Article - Durect Corp. (NASDAQ: DRRX) Making Surprising Moves in Monday Sess | whytestocks | investorshangout | 04/10/2023 5:05:48 PM |
100% agree. This will be a total loss | Distantpulse | investorshub | 12/07/2022 2:09:06 PM |
There is really nothing positive about a R/S | Foxwoods Man | investorshub | 12/06/2022 7:59:30 PM |
1/10 RS. 100% loss incoming. Smfh! | Distantpulse | investorshub | 12/06/2022 1:59:07 PM |
Been not liking this company since I was | Jimmy Joe | investorshub | 10/25/2022 8:45:12 PM |
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire - Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Earnings Call Today, M...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update PR Newswire CUPERTINO, Calif. , March 20, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering th...